PRENATRIX- ferrous fumarate, folic acid tablet 
PureTek Corporation

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Prenatrix

DESCRIPTION:

\Each caplet contains:

Vitamin A (as retinyl acetate)………………………….. 1500 mcg
Vitamin C (as ascorbic acid)……………………………… 120 mg
Vitamin D3 (as cholecalciferol)…………………………… 20 mcg
Vitamin E (dl-alpha tocopheryl acetate)…………………… 30 mg
Thiamin (as thiamine mononitrate)………………………… 3 mg
Riboflavin (vitamin B2)……………………………………. 3.4 mg
Niacin (as niacinamide)…………………………………… 20 mg
Vitamin B6 (as pyridoxine hydrochloride)…………………. 50 mg
Folate (as folic acid)……….. 1700 mcg DFE (1000 mcg folic acid)
Vitamin B12 (as cyanocobalamin)………………………… 10 mcg
Choline (as Choline Bitartrate)…………………………….. 55 mg
Calcium (as calcium carbonate)…………………………. 200 mg
Iron (as ferrous fumarate)………………………………… 27 mg
Iodine (as potassium iodine)…………………………….150 mcg
Magnesium (as magnesium oxide)……………………… 200 mg
Zinc (as zinc oxide)……………………………………….. 25 mg
Selenium (as selinium amino acid chelate)………………. 70 mcg
Manganese (as manganese sulfate)……………………… 2.6 mg
Chromium (as chromium polynicotinate)……………….. 45 mcg
Molybdenum (as molybdenum amino acid chelate)……… 50 mcg



Other Ingredients: BHT, dicalcium phosphate, croscarmellose sodium,
crospovidone, magnesium stearate, medium chain triglycerides, microcrystalline
cellulose, modified food starch, pork gelatin, starch aluminium octenyl succinate,
sodium ascorbate, sodium aluminum silicate, silicon dioxide, stearic acid, sucrose,
Clear Coating: (hydroxypropyl methylcellulose, PEG-8).

Indications

Prenatrix is indicated to provide vitamins and minerals to women
throughout pregnancy and during the postnatal period for both lactating and non-lactating
mothers, and throughout the childbearing years.
Prenatrix may be beneficial in improving the nutritional status of women prior to conception.

Contraindications:


This product is contraindicated in patients with known hypersensitivity to
any of its ingredients; also, all iron compounds are contraindicated in patients with
hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a
contraindication, as folic acid may obscure its signs and symptoms.

WARNING

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children
under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor
or poison control center immediately.
Administration of folic acid alone is improper therapy for pernicious anemia and other
megaloblastic anemias in which vitamin B12 is deficient.

Precautions

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that
hematologic remission can occur while neurological manifestations remain progressive.

There is a potential danger in administering folic acid to patients with undiagnosed anemia,
since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic
manifestations of the disease while allowing the neurologic complications to progress. This may
result in severe nervous system damage before the correct diagnosis is made. Adequate doses of
vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia.


The patient’s medical conditions and consumption of other drugs, herbs, and/or
supplements should be considered.


For use on the order of a healthcare practitioner.


Call your doctor about side effects. To report side effects, call PureTek Corporation at
1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Drug Interactions:


Prenatrix is not recommended for and should not be given to patients receiving
levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of
increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin,
Heparin or Clopidogrel).

Adverse Reactions:


Folic Acid: Allergic sensitizations have been reported following both oral and parenteral
administration of folic acid.
Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation)
occur occasionally, but are usually mild and may subside with continuation of therapy. Although the
absorption of iron is best when taken between meals, giving Prenatrix after meals may control
occasional gastrointestinal disturbances. Prenatrix is best absorbed when taken at bedtime.
Adverse reactions have been reported with specific vitamins and minerals but generally at levels
substantially higher than those contained herein. However, allergic and idiosyncratic reactions
are possible at lower levels. Iron, even at the usual recommended levels, has been associated
with gastrointestinal intolerance in some patients.

OVERDOSE:

Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and
vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include
pallor and cyanosis,melena, shock, drowsiness and coma. The estimated overdose of orally
ingested iron is 300 mg/kg body weight. When overdoses are ingested by children, severe
reactions, including fatalities, have resulted. Prenatrix should be stored beyond the reach of
children to prevent against accidental iron poisoning. Keep this and all other drugs out of
reach of children.

Treatment:

For specific therapy, exchange transfusion and chelating agents should be used. For
general management, perform gastric lavage with sodium bicarbonate solution or milk.
Administer intravenous fluids and electrolytes and use oxygen.

Dosage and Administration:


Adults (persons over 12 years of age) One (1) Prenatrix caplet
daily, between meals or as directed by a physician. Do not administer to children under the age
of 12.

HOW SUPPLIED

Prenatrix are yellow to brown speckled, oblong, coated caplets with "PT A18" debossed horizontally on one side,
bottles containing 30 caplets – NDC 59088-166-54. Dispense in a tight, light-resistant
container as defined in the USP/NF with a child resistant closure.
Store at controlled room temperature 20° to 25°C (68° to 77°F). [See USP]. Protect from light
and moisture and avoid excessive heat.

Storage

Do not use if bottle seal is broken.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Store at controlled room temperature 20° to 25°C (68° to 77°F). [See USP].
Protect from light and moisture and avoid excessive heat.
To report a serious adverse event or to obtain product information, contact 877-921-7873.

Prenatrix

Manufactured in the USA by:
PureTek Corporation
Panorama City, CA 91402
For questions or information
call toll-free: 877-921-7873

label

PRENATRIX 
ferrous fumarate, folic acid tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:59088-166
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE200 mg
MANGANESE SULFATE (UNII: W00LYS4T26) (MANGANESE CATION (2+) - UNII:H6EP7W5457) MANGANESE CATION (2+)2.6 mg
VITAMIN A ACETATE (UNII: 3LE3D9D6OY) (VITAMIN A - UNII:81G40H8B0T) VITAMIN A1500 ug
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID120 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL20 ug
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01) .ALPHA.-TOCOPHEROL, DL-30 mg
THIAMINE MONONITRATE (UNII: 8K0I04919X) (THIAMINE ION - UNII:4ABT0J945J) THIAMINE3 mg
RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN3.4 mg
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE20 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE50 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1000 ug
CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204) CYANOCOBALAMIN10 ug
CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CATION200 mg
FERROUS FUMARATE (UNII: R5L488RY0Q) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION27 mg
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION25 mg
MOLYBDENUM (UNII: 81AH48963U) (MOLYBDENUM - UNII:81AH48963U) MOLYBDENUM50 ug
CHOLINE BITARTRATE (UNII: 6K2W7T9V6Y) (CHOLINE - UNII:N91BDP6H0X) CHOLINE55 mg
CHROMIUM NICOTINATE (UNII: A150AY412V) (CHROMIC CATION - UNII:X1N4508KF1) CHROMIUM NICOTINATE45 ug
SELENIUM (UNII: H6241UJ22B) (SELENIUM - UNII:H6241UJ22B) SELENIUM70 ug
POTASSIUM IODIDE (UNII: 1C4QK22F9J) (IODIDE ION - UNII:09G4I6V86Q) POTASSIUM IODIDE150 ug
Inactive Ingredients
Ingredient NameStrength
SODIUM ASCORBATE (UNII: S033EH8359)  
STARCH, CORN (UNII: O8232NY3SJ)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
GELATIN (UNII: 2G86QN327L)  
ALUMINUM STARCH OCTENYLSUCCINATE (UNII: I9PJ0O6294)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
SUCROSE (UNII: C151H8M554)  
CROSPOVIDONE (UNII: 2S7830E561)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
HYDROXYMETHYL CELLULOSE (UNII: 273FM27VK1)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
SODIUM ALUMINIUM SILICATE (UNII: 058TS43PSM)  
Product Characteristics
Coloryellow ((Clear Coated Yellow to Brown speckled)) Scoreno score
ShapeCAPSULE ((Oblong Caplet)) Size19mm
FlavorImprint Code PT;A18
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:59088-166-5430 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product08/29/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/29/2020
Labeler - PureTek Corporation (785961046)

Revised: 2/2023
Document Id: f4352f0b-31d1-310c-e053-2a95a90a4d1d
Set id: ae07585b-e6e4-fd6d-e053-2995a90a7eec
Version: 6
Effective Time: 20230208
 
PureTek Corporation